Dr. Shou-Ching Tang to Serve as Associate Dean for Translational Research
Shou-Ching Tang, MD, PhD, FACP, FRCPC has agreed to serve as Associate Dean for Translational
Research. He will also serve as the Associate Director for Clinical Research at the
LSU-LCMC Cancer Center and Director of Phase I Clinical Trials Program.
Dr. Tang is a world-renowned clinician scientist and cancer center administrator with a passion for cancer clinical and translational research and breast cancer prevention, diagnosis and treatment.
He earned his medical degree with honors from West China University of Medical Sciences and a doctorate in molecular biology from the University of Alberta in Edmonton, Alberta, Canada. He completed his medical oncology fellowship at the Princess Margaret Hospital (Toronto, Canada) and is certified in medical oncology by the American Board of Internal Medicine and the Royal College of Physicians and Surgeons of Canada.
Dr. Tang comes to LSU Health Sciences Center from the University of Mississippi School
of Medicine where he served as the Associate Director for Clinical and Translational
Research at the Cancer and Research Institute, Director of Phase I Clinical Trials
and Interdisciplinary Experimental Therapeutic Program and Chair of Clinical Leadership
Council for the Cancer Service Line at the University of Mississippi Medical Center.
Dr. Tang founded the Asia International Breast Cancer Summit, the Atlantic Canada
Oncology Group (ACOG) and the US Chinese Anticancer Association (USCACA). He has held
many leadership and administrative positions at academic institutions and NCI-Designated
Cancer Centers. His translational research is focused on oncogenesis, drug resistance,
molecular immunology and prognostic and predictive biomarkers. Notably, his laboratory
discovered the anti-apoptotic protein BAG-1 as a prognostic factor in solid tumors
and developed novel BAG-1-targeted therapy. Dr. Tang currently has three active ACS/DOD
grants for which he serves as co-investigator or collaborator. He has published 145
peer-reviewed papers and serves on the editorial board of six peer-reviewed international
journals.